---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-009033"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2024-03-06T23:59:59+00:00"
generated_at: "2026-06-05T02:31:17.758402+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Bone Biologics closes $2.0M public offering of shares and warrants; net proceeds ~$1.5M

## Summary
- Priced 119,000 shares and 662,251 pre-funded warrants, each with warrants to buy one share at $2.43.
- Combined offering price $2.56 per share and warrant; net proceeds ~$1.5M after fees.
- Warrants exercisable immediately, expire in 5 years; exercise price $2.43.
- Proceeds to fund clinical trials, patent portfolio, and working capital.
- After closing, shares outstanding increased to 879,176.

## SEC filing metadata
- accession: 0001493152-24-009033
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2024-03-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000149315224009033/0001493152-24-009033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000149315224009033/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-009033
- JSON: https://secwatch.observer/filing/0001493152-24-009033.json
- Plain text: https://secwatch.observer/filing/0001493152-24-009033.txt

## Key facts
- Material Agreements
  Bone Biologics Corp entered into Securities Purchase Agreement with certain institutional investors valued at Combined offering price of $2.56 per Share and accompanying Warrant and $2.559 per Pre-Funded Warran (effective 2024-03-04).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain institutional investors
  - Value: Combined offering price of $2.56 per Share and accompanying Warrant and $2.559 per Pre-Funded Warran
  - Effective: 2024-03-04
  source text: On March 4, 2024, Bone Biologics Corporation (the “Company”) priced a public offering (the “Offering”) of (i) 119,000 shares (the “Shares”) of its common stock, par value $0.001 per share (the “Common Stock”), together with warrants (the “Warrants”) to purchase 119,000 shares of Common Stock at a combined public offering price of $2.56 per Share and accompanying Warrant and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase 662,251 shares of Common Stock, together with Warrants to purchase 662,251 shares of Common Stock at a combined public offering price of $2.559 per Pre-Funded Warrant and accompanying Warrant.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1419554/000149315224009033/0001493152-24-009033-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.